デフォルト表紙
市場調査レポート
商品コード
1469135

ライフサイエンスおよび化学計装市場- 世界の産業規模、シェア、動向、機会、予測、技術別、エンドユーザー別、地域別、競合別、2019年~2029年

Life Science and Chemical Instrumentation Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Technology, By End-User, By Region, Competition, 2019-2029F

出版日: | 発行: TechSci Research | ページ情報: 英文 182 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

ライフサイエンスおよび化学計装市場- 世界の産業規模、シェア、動向、機会、予測、技術別、エンドユーザー別、地域別、競合別、2019年~2029年
出版日: 2024年04月23日
発行: TechSci Research
ページ情報: 英文 182 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

ライフサイエンスおよび化学計装の世界市場は、2023年に542億5,000万米ドルと評価され、2029年までのCAGRは6.40%で、予測期間中に目覚ましい成長を遂げると予測されています。

ライフサイエンスおよび化学計装の世界の状況は、ダイナミックで継続的に進化する分野であり、科学研究、診断、産業アプリケーションの推進に不可欠です。この広大な市場には、生物学的・化学的物質を比類のない精度と正確さで分析・測定・操作するために綿密に作られた、多様で洗練された機器が網羅されています。その成長軌道は、その進路に影響を与えるだけでなく、世界の様々な分野に大きな影響を残す要因の融合によって推進されています。ライフサイエンスおよび化学機器に関連する多くの利点に関する意識の高まりは、世界規模での積極的な成長の触媒として機能すると予想されます。効率性、生産性、革新性を高める上で、これらの機器が果たす不可欠な役割が産業界で認識され続けていることから、市場は持続的な拡大を示し、科学的努力と産業の進歩を促進する上で極めて重要な地位をさらに強固なものにするものと思われます。

市場促進要因

技術の進歩と革新

医薬品開発と個別化医療に対する需要の増加

環境検査への注目の拡大

主な市場課題

先端機器のコスト高

急速な技術の陳腐化

複雑さと専門知識の必要性

主な市場動向

自動化とロボット工学の統合

データ分析と機械学習の進歩

持続可能性とグリーンケミストリーへの注力

セグメント別インサイト

技術別インサイト

エンドユーザー別インサイト

地域別インサイト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 ライフサイエンスおよび化学計装の世界市場展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 技術別(ポリメラーゼ連鎖反応(PCR)、DNAシーケンサー増幅器、フローサイトメトリー、分光法、電気泳動、クロマトグラフィー、遠心分離機、その他)
    • エンドユーザー別(病院・診断センター、製薬・バイオテクノロジー企業、CRO(医薬品開発業務受託機関)、学術・研究機関)
    • 地域別
    • 企業別(2023年)
  • 市場マップ
    • 技術別
    • エンドユーザー別
    • 地域別

第6章 アジア太平洋地域のライフサイエンスおよび化学計装市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 技術別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国

第7章 欧州のライフサイエンスおよび化学計装市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 技術別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • 英国

第8章 北米のライフサイエンスおよび化学計装市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 技術別
    • エンドユーザー別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第9章 南米のライフサイエンスおよび化学計装市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 技術別
    • エンドユーザー別
    • 国別
  • 南米::国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのライフサイエンスおよび化学計装市場の展望

  • 市場規模予測
    • 金額別
  • 市場シェア予測
    • 技術別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品発表
  • 合併・買収

第13章 ライフサイエンスおよび化学計装の世界市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Agilent Technologies Inc
  • Becton, Dickinson Company
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc.
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

第16章 戦略的提言

第17章 免責事項

目次
Product Code: 16095

Global Life Science and Chemical Instrumentation Market was valued at USD 54.25 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.40% through 2029. The global landscape of life science and chemical instrumentation represents a dynamic and continually evolving arena, crucial for driving forward scientific research, diagnostics, and industrial applications. This expansive market encompasses a diverse array of sophisticated instruments meticulously crafted to analyze, measure, and manipulate biological and chemical substances with unparalleled precision and accuracy. Its growth trajectory is propelled by a fusion of factors that not only influence its course but also leave a significant impact on various sectors worldwide. The increasing awareness regarding the multitude of benefits associated with life science and chemical instrumentation is anticipated to serve as a catalyst for positive growth on a global scale. As industries continue to recognize the indispensable role played by these instruments in enhancing efficiency, productivity, and innovation, the market is poised to witness sustained expansion, further solidifying its pivotal position in advancing scientific endeavors and industrial progress.

Key Market Drivers

Technological Advancements and Innovations

Technological advancements and innovations play a pivotal role in driving the life science and chemical instrumentation market forward. As industries across sectors continuously pursue more precise and sophisticated analytical tools, technology responds by introducing groundbreaking solutions that redefine the boundaries of research and analysis. The rapid pace of technological innovation has resulted in the emergence of cutting-edge instruments such as high-performance liquid chromatography (HPLC), mass spectrometry, and next-generation spectroscopy techniques. These innovative instruments offer unprecedented levels of sensitivity, accuracy, and automation, addressing the intricate challenges encountered in modern scientific research. Researchers increasingly demand instruments capable of delivering faster results, utilizing minimal sample volumes, and performing complex analyses across a broad spectrum of applications. As technology continues to evolve, it empowers researchers to explore new frontiers, unravel complex molecular structures, and achieve groundbreaking discoveries that were previously unattainable. By providing researchers with advanced tools and capabilities, technological advancements drive progress in life sciences and chemistry, facilitating innovation and driving the growth of the instrumentation market.

Increasing Demand for Drug Development and Personalized Medicine

The surging demand for drug development and personalized medicine stands out as a pivotal driving force propelling the life science and chemical instrumentation market forward. In response to evolving medical needs, both the pharmaceutical and biotechnology sectors increasingly rely on cutting-edge analytical instruments to expedite the discovery, development, and quality control of novel therapeutic agents. The pharmaceutical industry remains steadfast in its pursuit of innovative drugs capable of tackling diverse medical challenges. Moreover, with the advent of personalized medicine, there's a heightened emphasis on tailored treatments designed to address the unique profiles of individual patients. This burgeoning demand underscores the critical importance of employing highly sensitive instruments adept at identifying precise molecular structures, evaluating drug interactions, and ensuring the safety of pharmaceutical products. Consequently, the life science and chemical instrumentation market witnesses sustained growth, driven by pharmaceutical companies' investments in advanced tools aimed at augmenting their research capabilities and streamlining drug development processes. As these companies strive to remain at the forefront of innovation, the market continues to expand, offering a diverse array of sophisticated instruments tailored to meet the evolving needs of the pharmaceutical and biotechnology sectors.

Expanding Focus on Environmental Testing

The surge in global attention towards environmental sustainability and regulatory compliance is fueling a heightened demand for cutting-edge life science and chemical instrumentation solutions tailored for environmental testing and analysis. In today's world, environmental concerns have reached a critical juncture, prompting governments and industries worldwide to enact stringent regulations and adopt rigorous monitoring practices. Consequently, analytical instruments have emerged as indispensable tools for evaluating air, water, and soil quality with precision and accuracy. Key instruments such as gas chromatographs, mass spectrometers, and environmental analyzers play a pivotal role in identifying pollutants, quantifying contaminants, and ensuring adherence to environmental standards. The pressing need to combat pollution, safeguard public health, and meet regulatory requirements is driving the quest for innovative instrumentation capable of delivering timely, reliable, and precise results. The global life science and chemical instrumentation market is characterized by a confluence of influential factors that collectively steer its growth and evolution. The synergy between technological advancements, the escalating demand for drug development and personalized medicine, and the expanding focus on environmental testing creates a fertile ground for innovation and progress. As industries adapt to changing dynamics and societal needs evolve, these driving forces will continue to shape the trajectory of the life science and chemical instrumentation market, paving the way for advancements that address critical global challenges.

Key Market Challenges

Cost-Intensive Nature of Advanced Instrumentation

One of the primary challenges in the life science and chemical instrumentation market is the high cost associated with advanced analytical instruments.Developing cutting-edge analytical instruments involves extensive research and development efforts. The costs associated with designing, prototyping, and testing new technologies contribute to the overall high price of these instruments. The continuous drive for innovation and the incorporation of sophisticated technologies such as mass spectrometry, nuclear magnetic resonance (NMR), and high-resolution microscopy contribute to the intricate design of instruments. This complexity adds to the production cost. Manufacturers must adhere to stringent quality control standards and regulatory requirements to ensure the accuracy, precision, and reliability of instruments. Meeting these standards incurs additional costs in terms of testing, validation, and certification.The niche nature of many advanced instruments limits the potential for achieving economies of scale in production. Unlike mass-produced consumer goods, these instruments are often custom-built to cater to specific research needs, which can drive up production costs.

Rapid Technological Obsolescence

The life science and chemical instrumentation market faces the constant challenge of technological obsolescence, wherein newer innovations quickly replace existing technologies.The rapid pace of technological evolution means that instruments developed just a few years ago may become outdated as newer, more efficient technologies emerge. Researchers are often inclined to invest in the latest innovations to maintain their competitive edge. Instruments in this market experience shorter product lifecycles due to the rapid pace of innovation. Manufacturers must continually invest in research and development to stay ahead, resulting in frequent product launches and updates. As newer technologies emerge, compatibility and integration with existing systems become a challenge. Researchers and organizations must carefully assess the integration capabilities of new instruments with their current infrastructure.

Complexity and Expertise Requirements

The complexity of advanced life science and chemical instrumentation necessitates a high level of expertise for operation and maintenance.Instruments such as mass spectrometers, atomic force microscopes, and nuclear magnetic resonance machines require specialized knowledge for their proper operation. Researchers and technicians must be well-trained to handle these intricate instruments effectively.The data generated by advanced instruments is often complex and requires expert interpretation. Researchers need a deep understanding of analytical techniques and data analysis to extract meaningful insights from the results. Regular maintenance, calibration, and troubleshooting are essential to ensure accurate and reliable results. The intricacy of these instruments demands specialized training for maintenance personnel. The demand for skilled professionals who can operate, maintain, and interpret data from advanced instruments often exceeds the supply. This skills gap poses a challenge for organizations seeking to fully utilize their investment in sophisticated equipment.The challenges faced by the global life science and chemical instrumentation market are multifaceted and intricately connected to the nature of the industry. The high cost of advanced instrumentation, rapid technological obsolescence, and the complexity of operation and maintenance pose significant hurdles. To overcome these challenges, manufacturers and researchers must continue to innovate, collaborate, and invest in training and development to ensure that this crucial industry continues to evolve and thrive.

Key Market Trends

Integration of Automation and Robotics

A notable trend in the life science and chemical instrumentation market is the increasing integration of automation and robotics into analytical workflows. This strategic adoption of automation and robotics optimizes various repetitive tasks, including sample preparation, data acquisition, and analysis. As a result, researchers experience heightened efficiency, enabling them to manage larger sample volumes and data sets within shorter timeframes. Automation significantly mitigates the risk of human errors, thereby enhancing the accuracy and reproducibility of results, which is particularly critical in fields like drug discovery and quality control. Moreover, automated systems operate continuously, facilitating round-the-clock data collection and analysis, thereby expediting time-sensitive experiments and enabling long-duration studies. Additionally, automation systems generate comprehensive data logs, ensuring traceability and transparency throughout the analytical process, a crucial aspect for regulatory compliance and audit requirements. Furthermore, the integration of robotics enables the execution of complex experimental designs and high-throughput screening, thereby facilitating the exploration of a broader spectrum of scientific inquiries and hypotheses.

Advancements in Data Analytics and Machine Learning

The life science and chemical instrumentation market is experiencing notable advancements in data analytics and machine learning, revolutionizing the way researchers extract insights from vast datasets. As sophisticated instrumentation proliferates, there is a corresponding surge in both the volume and complexity of generated data. In this landscape, the utilization of data analytics tools and machine learning algorithms becomes indispensable for uncovering meaningful patterns and correlations within intricate datasets. Machine learning techniques empower researchers to identify nuanced trends and potential interactions, facilitating novel discoveries that may elude traditional analysis methods.The machine learning algorithms have diverse applications across various research domains, including drug discovery and material science. By leveraging historical data, these advanced algorithms can predict outcomes and trends, guiding research efforts towards promising avenues. Additionally, machine learning contributes to the advancement of personalized medicine approaches by enabling the analysis of individual patient data and tailoring treatment strategies to suit patients' unique genetic profiles. Furthermore, data analytics optimize experimental conditions and instrument parameters, enhancing efficiency, accuracy, and resource utilization in scientific endeavors.

Focus on Sustainability and Green Chemistry

Within the life science and chemical instrumentation market, there's a burgeoning focus on sustainability and green chemistry practices. This shift is driven by a mounting awareness of environmental impacts, prompting researchers and industries to seek methods for reducing ecological footprints. Green chemistry principles advocate for the use of eco-friendly solvents, waste reduction, and energy-efficient methodologies. As environmental regulations tighten, industries are compelled to adopt sustainable practices to ensure compliance. Embracing green chemistry not only reduces resource consumption, waste, and energy usage but also yields substantial cost savings for research institutions and industries. Aligning with consumer expectations for ethical and environmentally responsible operations enhances a company's public perception and reputation. The pursuit of green chemistry practices fosters the development of innovative, eco-friendly technologies and processes, heralding a transformative era in analytical instrumentation. These trends underscore the industry's evolution toward greater efficiency, precision, and sustainability. Integration of automation, advancements in data analytics and machine learning, and the emphasis on sustainability drive the industry forward, empowering researchers and industries to explore new frontiers in scientific discovery and technological advancement.

Segmental Insights

Technology Insights

Based on Technology, the Polymerase Chain Reaction (PCR) segment emerged as the dominant segment in the global market for Life Science and Chemical Instrumentation in 2023. Polymerase Chain Reaction (PCR) has emerged as a cornerstone technology in the global life science and chemical instrumentation market, asserting its dominance for a myriad of reasons and insights. This groundbreaking technique has revolutionized molecular biology and diagnostics, offering unparalleled advantages that drive its widespread adoption and market leadership. PCR delivers exceptional accuracy and sensitivity in detecting and amplifying specific DNA sequences, making it a versatile tool for applications spanning genetic research to clinical diagnostics. Its versatility is evident across various formats, including traditional PCR, real-time quantitative PCR (qPCR), and digital PCR (dPCR), each tailored to specific research and diagnostic needs. PCR plays a pivotal role in disease diagnosis and monitoring, facilitating the detection of genetic mutations, pathogens, and viral infections, crucial for early detection and treatment decisions. Moreover, PCR supports genetic research by enabling the amplification of DNA segments for sequencing and analysis, essential for understanding genetic variations and disease associations. In forensic science, PCR aids in DNA profiling, enabling the identification of individuals based on trace amounts of DNA at crime scenes. Furthermore, PCR drives biotechnological advancements by aiding in gene cloning, recombinant DNA technology, and genetically modified organism production. Additionally, it enhances quality control in the pharmaceutical industry by identifying specific genetic markers related to drug responses and disease susceptibility, integral for personalized medicine approaches.

End-User Insights

Based on End-User, the Pharmaceutical and Biotechnology Companies segment emerged as the dominant player in the global market for Life Science and Chemical Instrumentation in 2023. This is due toits direct involvement in biopharmaceutical manufacturing. These companies rely heavily on sophisticated instrumentation for research, development, and quality control processes. The demand for precise and efficient analytical tools to ensure product safety and efficacy drives their investment in cutting-edge instrumentation. Additionally, stringent regulatory requirements necessitate adherence to high standards of quality and accuracy, further reinforcing the reliance on advanced instrumentation. As key stakeholders in the life science and chemical industries, pharmaceutical and biotechnology companies wield significant influence and resources, solidifying their position as leaders in instrumentation adoption and innovation.

Regional Insights

North America emerged as the dominant region in the global Life Science and Chemical Instrumentation market in 2023, driven by its robust research infrastructure and a history of pioneering breakthroughs. The region's close collaboration between academia and industry fosters innovation and drives demand for cutting-edge instrumentation. With stringent regulatory standards and a substantial investment in research and development, North America creates a fertile market for advanced instrumentation, particularly in pharmaceutical and biotechnological sectors.

Meanwhile, the Asia-Pacific market presents promising growth opportunities, fueled by expanding biotechnology and pharmaceutical sectors, rising healthcare spending, and increased investment in research and development initiatives, especially in emerging economies like China and India. This growth trajectory underscores the region's potential to become a key player in the global Life Science and Chemical Instrumentation market

Key Market Players

Agilent Technologies Inc.

Becton, Dickinson Company

Bio-Rad Laboratories Inc.

Bruker Corporation

Danaher Corporation

F. Hoffmann-La Roche Ltd

Illumina Inc.

PerkinElmer Inc.

Thermo Fisher Scientific Inc.

Waters Corporation

Report Scope:

In this report, the Global Life Science and Chemical Instrumentation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Life Science and Chemical Instrumentation Market,By Technology:

  • Polymerase Chain Reaction (PCR)
  • DNA Sequencers Amplifiers
  • Flow Cytometry
  • Spectroscopy
  • Electrophoresis
  • Chromatography
  • Centrifuges
  • Other

Life Science and Chemical Instrumentation Market,By End-User:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organization (CRO)
  • Academia and Research Institutes

Life Science and Chemical Instrumentation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Life Science and Chemical Instrumentation Market.

Available Customizations:

Global Life Science and Chemical Instrumentation marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

  • 1.1.Market Definition
  • 1.2.Scope of the Market
    • 1.2.1.Markets Covered
    • 1.2.2.Years Considered for Study
    • 1.2.3.Key Market Segmentations

2.Research Methodology

  • 2.1.Objective of the Study
  • 2.2.Baseline Methodology
  • 2.3.Key Industry Partners
  • 2.4.Major Association and Secondary Sources
  • 2.5.Forecasting Methodology
  • 2.6.Data Triangulation Validation
  • 2.7.Assumptions and Limitations

3.Executive Summary

  • 3.1.Overview of the Market
  • 3.2.Overview of Key Market Segmentations
  • 3.3.Overview of Key Market Players
  • 3.4.Overview of Key Regions/Countries
  • 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Life Science and Chemical Instrumentation Market Outlook

  • 5.1.Market Size Forecast
    • 5.1.1.By Value
  • 5.2.Market Share Forecast
    • 5.2.1.By Technology (Polymerase Chain Reaction (PCR), DNA Sequencers Amplifiers, Flow Cytometry, Spectroscopy, Electrophoresis, Chromatography, Centrifuges, Other)
    • 5.2.2.By End-User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organization (CRO), Academia and Research Institutes)
    • 5.2.3.By Region
    • 5.2.4.By Company (2023)
  • 5.3.Market Map
    • 5.3.1.By Technology
    • 5.3.2.By End-User
    • 5.3.3.By Region

6.Asia Pacific Life Science and Chemical Instrumentation Market Outlook

  • 6.1.Market Size Forecast
    • 6.1.1.By Value
  • 6.2.Market Share Forecast
    • 6.2.1.By Technology
    • 6.2.2.By End-User
    • 6.2.3.By Country
  • 6.3.Asia Pacific: Country Analysis
    • 6.3.1.China Life Science and Chemical Instrumentation Market Outlook
      • 6.3.1.1.Market Size Forecast
        • 6.3.1.1.1.By Value
      • 6.3.1.2.Market Share Forecast
        • 6.3.1.2.1.By Technology
        • 6.3.1.2.2.By End-User
    • 6.3.2.India Life Science and Chemical Instrumentation Market Outlook
      • 6.3.2.1.Market Size Forecast
        • 6.3.2.1.1.By Value
      • 6.3.2.2.Market Share Forecast
        • 6.3.2.2.1.By Technology
        • 6.3.2.2.2.By End-User
    • 6.3.3.Australia Life Science and Chemical Instrumentation Market Outlook
      • 6.3.3.1.Market Size Forecast
        • 6.3.3.1.1.By Value
      • 6.3.3.2.Market Share Forecast
        • 6.3.3.2.1.By Technology
        • 6.3.3.2.2.By End-User
    • 6.3.4.Japan Life Science and Chemical Instrumentation Market Outlook
      • 6.3.4.1.Market Size Forecast
        • 6.3.4.1.1.By Value
      • 6.3.4.2.Market Share Forecast
        • 6.3.4.2.1.By Technology
        • 6.3.4.2.2.By End-User
    • 6.3.5.South Korea Life Science and Chemical Instrumentation Market Outlook
      • 6.3.5.1.Market Size Forecast
        • 6.3.5.1.1.By Value
      • 6.3.5.2.Market Share Forecast
        • 6.3.5.2.1.By Technology
        • 6.3.5.2.2.By End-User

7.Europe Life Science and Chemical Instrumentation Market Outlook

  • 7.1.Market Size Forecast
    • 7.1.1.By Value
  • 7.2.Market Share Forecast
    • 7.2.1.By Technology
    • 7.2.2.By End-User
    • 7.2.3.By Country
  • 7.3.Europe: Country Analysis
    • 7.3.1.France Life Science and Chemical Instrumentation Market Outlook
      • 7.3.1.1.Market Size Forecast
        • 7.3.1.1.1.By Value
      • 7.3.1.2.Market Share Forecast
        • 7.3.1.2.1.By Technology
        • 7.3.1.2.2.By End-User
    • 7.3.2.Germany Life Science and Chemical Instrumentation Market Outlook
      • 7.3.2.1.Market Size Forecast
        • 7.3.2.1.1.By Value
      • 7.3.2.2.Market Share Forecast
        • 7.3.2.2.1.By Technology
        • 7.3.2.2.2.By End-User
    • 7.3.3.Spain Life Science and Chemical Instrumentation Market Outlook
      • 7.3.3.1.Market Size Forecast
        • 7.3.3.1.1.By Value
      • 7.3.3.2.Market Share Forecast
        • 7.3.3.2.1.By Technology
        • 7.3.3.2.2.By End-User
    • 7.3.4.Italy Life Science and Chemical Instrumentation Market Outlook
      • 7.3.4.1.Market Size Forecast
        • 7.3.4.1.1.By Value
      • 7.3.4.2.Market Share Forecast
        • 7.3.4.2.1.By Technology
        • 7.3.4.2.2.By End-User
    • 7.3.5.United Kingdom Life Science and Chemical Instrumentation Market Outlook
      • 7.3.5.1.Market Size Forecast
        • 7.3.5.1.1.By Value
      • 7.3.5.2.Market Share Forecast
        • 7.3.5.2.1.By Technology
        • 7.3.5.2.2.By End-User

8.North America Life Science and Chemical Instrumentation Market Outlook

  • 8.1.Market Size Forecast
    • 8.1.1.By Value
  • 8.2.Market Share Forecast
    • 8.2.1.By Technology
    • 8.2.2.By End-User
    • 8.2.3.By Country
  • 8.3.North America: Country Analysis
    • 8.3.1.United States Life Science and Chemical Instrumentation Market Outlook
      • 8.3.1.1.Market Size Forecast
        • 8.3.1.1.1.By Value
      • 8.3.1.2.Market Share Forecast
        • 8.3.1.2.1.By Technology
        • 8.3.1.2.2.By End-User
    • 8.3.2.Mexico Life Science and Chemical Instrumentation Market Outlook
      • 8.3.2.1.Market Size Forecast
        • 8.3.2.1.1.By Value
      • 8.3.2.2.Market Share Forecast
        • 8.3.2.2.1.By Technology
        • 8.3.2.2.2.By End-User
    • 8.3.3.Canada Life Science and Chemical Instrumentation Market Outlook
      • 8.3.3.1.Market Size Forecast
        • 8.3.3.1.1.By Value
      • 8.3.3.2.Market Share Forecast
        • 8.3.3.2.1.By Technology
        • 8.3.3.2.2.By End-User

9.South America Life Science and Chemical Instrumentation Market Outlook

  • 9.1.Market Size Forecast
    • 9.1.1.By Value
  • 9.2.Market Share Forecast
    • 9.2.1.By Technology
    • 9.2.2.By End-User
    • 9.2.3.By Country
  • 9.3.South America: Country Analysis
    • 9.3.1.Brazil Life Science and Chemical Instrumentation Market Outlook
      • 9.3.1.1.Market Size Forecast
        • 9.3.1.1.1.By Value
      • 9.3.1.2.Market Share Forecast
        • 9.3.1.2.1.By Technology
        • 9.3.1.2.2.By End-User
    • 9.3.2.Argentina Life Science and Chemical Instrumentation Market Outlook
      • 9.3.2.1.Market Size Forecast
        • 9.3.2.1.1.By Value
      • 9.3.2.2.Market Share Forecast
        • 9.3.2.2.1.By Technology
        • 9.3.2.2.2.By End-User
    • 9.3.3.Colombia Life Science and Chemical Instrumentation Market Outlook
      • 9.3.3.1.Market Size Forecast
        • 9.3.3.1.1.By Value
      • 9.3.3.2.Market Share Forecast
        • 9.3.3.2.1.By Technology
        • 9.3.3.2.2.By End-User

10.Middle East and Africa Life Science and Chemical Instrumentation Market Outlook

  • 10.1.Market Size Forecast
    • 10.1.1.By Value
  • 10.2.Market Share Forecast
    • 10.2.1.By Technology
    • 10.2.2.By End-User
    • 10.2.3.By Country
  • 10.3.MEA: Country Analysis
    • 10.3.1.South Africa Life Science and Chemical Instrumentation Market Outlook
      • 10.3.1.1.Market Size Forecast
        • 10.3.1.1.1.By Value
      • 10.3.1.2.Market Share Forecast
        • 10.3.1.2.1.By Technology
        • 10.3.1.2.2.By End-User
    • 10.3.2.Saudi Arabia Life Science and Chemical Instrumentation Market Outlook
      • 10.3.2.1.Market Size Forecast
        • 10.3.2.1.1.By Value
      • 10.3.2.2.Market Share Forecast
        • 10.3.2.2.1.By Technology
        • 10.3.2.2.2.By End-User
    • 10.3.3.UAE Life Science and Chemical Instrumentation Market Outlook
      • 10.3.3.1.Market Size Forecast
        • 10.3.3.1.1.By Value
      • 10.3.3.2.Market Share Forecast
        • 10.3.3.2.1.By Technology
        • 10.3.3.2.2.By End-User
    • 10.3.4.Egypt Life Science and Chemical Instrumentation Market Outlook
      • 10.3.4.1.Market Size Forecast
        • 10.3.4.1.1.By Value
      • 10.3.4.2.Market Share Forecast
        • 10.3.4.2.1.By Technology
        • 10.3.4.2.2.By End-User

11.Market Dynamics

  • 11.1.Drivers
  • 11.2.Challenges

12.Market Trends Developments

  • 12.1.Recent Developments
  • 12.2.Product Launches
  • 12.3.Mergers Acquisitions

13.Global Life Science and Chemical Instrumentation Market: SWOT Analysis

14.Porter's Five Forces Analysis

  • 14.1.Competition in the Industry
  • 14.2.Potential of New Entrants
  • 14.3.Power of Suppliers
  • 14.4.Power of Customers
  • 14.5.Threat of Substitute Product

15.Competitive Landscape

  • 15.1.Agilent Technologies Inc
    • 15.1.1.Business Overview
    • 15.1.2.Company Snapshot
    • 15.1.3.Products Services
    • 15.1.4.Financials (In case of listed)
    • 15.1.5.Recent Developments
    • 15.1.6.SWOT Analysis
  • 15.2.Becton, Dickinson Company
  • 15.3.Bio-Rad Laboratories Inc.
  • 15.4.Bruker Corporation
  • 15.5.Danaher Corporation
  • 15.6.F. Hoffmann-La Roche Ltd
  • 15.7.Illumina Inc.
  • 15.8.PerkinElmer Inc.
  • 15.9.Thermo Fisher Scientific Inc.
  • 15.10.Waters Corporation

16.Strategic Recommendations

17.About Us Disclaimer